Global Endometriosis Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 8082

Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market.

The global Endometriosis Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Endometriosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
AbbVie
Astellas Pharma
AstraZeneca
Debiopharm Group
Evotec AG
Kissei Pharmaceutical
Neurocrine Biosciences
ObsEva
Pfizer
Repros Therapeutics
Roivant Sciences GmbH
Takeda Pharmaceutical Company Limited
ValiRx

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs

Segment by Application
Hospitals
Clinics
Research Institutes

Table of Contents

Executive Summary
1 Endometriosis Drugs Market Overview
1.1 Product Overview and Scope of Endometriosis Drugs
1.2 Endometriosis Drugs Segment by Type
1.2.1 Global Endometriosis Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Hormonal Therapy
1.2.3 Add-back Medication
1.2.4 Progestogens
1.2.5 Chinese Herbs
1.3 Endometriosis Drugs Segment by Application
1.3.1 Endometriosis Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Global Endometriosis Drugs Market by Region
1.4.1 Global Endometriosis Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Endometriosis Drugs Market Size
1.5.1 Global Endometriosis Drugs Revenue (2014-2025)
1.5.2 Global Endometriosis Drugs Production (2014-2025)

2 Global Endometriosis Drugs Market Competition by Manufacturers
2.1 Global Endometriosis Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Endometriosis Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Endometriosis Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Endometriosis Drugs Production Sites, Area Served, Product Types
2.5 Endometriosis Drugs Market Competitive Situation and Trends
2.5.1 Endometriosis Drugs Market Concentration Rate
2.5.2 Endometriosis Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Endometriosis Drugs Production Market Share by Regions
3.1 Global Endometriosis Drugs Production Market Share by Regions
3.2 Global Endometriosis Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Endometriosis Drugs Production
3.4.1 North America Endometriosis Drugs Production Growth Rate (2014-2019)
3.4.2 North America Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Endometriosis Drugs Production
3.5.1 Europe Endometriosis Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Endometriosis Drugs Production (2014-2019)
3.6.1 China Endometriosis Drugs Production Growth Rate (2014-2019)
3.6.2 China Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Endometriosis Drugs Production (2014-2019)
3.7.1 Japan Endometriosis Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Endometriosis Drugs Consumption by Regions
4.1 Global Endometriosis Drugs Consumption by Regions
4.2 North America Endometriosis Drugs Consumption (2014-2019)
4.3 Europe Endometriosis Drugs Consumption (2014-2019)
4.4 China Endometriosis Drugs Consumption (2014-2019)
4.5 Japan Endometriosis Drugs Consumption (2014-2019)

5 Global Endometriosis Drugs Production, Revenue, Price Trend by Type
5.1 Global Endometriosis Drugs Production Market Share by Type (2014-2019)
5.2 Global Endometriosis Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Endometriosis Drugs Price by Type (2014-2019)
5.4 Global Endometriosis Drugs Production Growth by Type (2014-2019)

6 Global Endometriosis Drugs Market Analysis by Applications
6.1 Global Endometriosis Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Endometriosis Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Endometriosis Drugs Business
7.1 AbbVie
7.1.1 AbbVie Endometriosis Drugs Production Sites and Area Served
7.1.2 Endometriosis Drugs Product Introduction, Application and Specification
7.1.3 AbbVie Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Astellas Pharma
7.2.1 Astellas Pharma Endometriosis Drugs Production Sites and Area Served
7.2.2 Endometriosis Drugs Product Introduction, Application and Specification
7.2.3 Astellas Pharma Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 AstraZeneca
7.3.1 AstraZeneca Endometriosis Drugs Production Sites and Area Served
7.3.2 Endometriosis Drugs Product Introduction, Application and Specification
7.3.3 AstraZeneca Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Debiopharm Group
7.4.1 Debiopharm Group Endometriosis Drugs Production Sites and Area Served
7.4.2 Endometriosis Drugs Product Introduction, Application and Specification
7.4.3 Debiopharm Group Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Evotec AG
7.5.1 Evotec AG Endometriosis Drugs Production Sites and Area Served
7.5.2 Endometriosis Drugs Product Introduction, Application and Specification
7.5.3 Evotec AG Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Kissei Pharmaceutical
7.6.1 Kissei Pharmaceutical Endometriosis Drugs Production Sites and Area Served
7.6.2 Endometriosis Drugs Product Introduction, Application and Specification
7.6.3 Kissei Pharmaceutical Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Neurocrine Biosciences
7.7.1 Neurocrine Biosciences Endometriosis Drugs Production Sites and Area Served
7.7.2 Endometriosis Drugs Product Introduction, Application and Specification
7.7.3 Neurocrine Biosciences Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 ObsEva
7.8.1 ObsEva Endometriosis Drugs Production Sites and Area Served
7.8.2 Endometriosis Drugs Product Introduction, Application and Specification
7.8.3 ObsEva Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Pfizer
7.9.1 Pfizer Endometriosis Drugs Production Sites and Area Served
7.9.2 Endometriosis Drugs Product Introduction, Application and Specification
7.9.3 Pfizer Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Repros Therapeutics
7.10.1 Repros Therapeutics Endometriosis Drugs Production Sites and Area Served
7.10.2 Endometriosis Drugs Product Introduction, Application and Specification
7.10.3 Repros Therapeutics Endometriosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Roivant Sciences GmbH
7.12 Takeda Pharmaceutical Company Limited
7.13 ValiRx

8 Endometriosis Drugs Manufacturing Cost Analysis
8.1 Endometriosis Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Endometriosis Drugs
8.4 Endometriosis Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Endometriosis Drugs Distributors List
9.3 Endometriosis Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Endometriosis Drugs Market Forecast
11.1 Global Endometriosis Drugs Production, Revenue Forecast
11.1.1 Global Endometriosis Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Endometriosis Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Endometriosis Drugs Price and Trend Forecast (2019-2025)
11.2 Global Endometriosis Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Endometriosis Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Endometriosis Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Endometriosis Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Endometriosis Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Endometriosis Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Endometriosis Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Endometriosis Drugs Consumption Forecast (2019-2025)
11.3.3 China Endometriosis Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Endometriosis Drugs Consumption Forecast (2019-2025)
11.4 Global Endometriosis Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Endometriosis Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer